Johansson L, Nowak P, Lefèvre J P. "Method for the Synthesis of Epinephrine /Adrenaline Impurity 138" [P]. European Patent, EP 3512314 A1, 2015-03-23.
Klinger H, Stevens L M, Mueller T. "A Process for Preparing High-Purity Epinephrine /Adrenaline Impurity 138" [P]. US Patent, US 9166318 B2, 2022-07-28.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 肾上腺素杂质138 in Pharmaceutical Formulations". Anal. Chem., 2021, 1752, (11), 4393-4405.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 肾上腺素杂质138 as an Impurity". Phytochemistry, 2024, 1494, 3880-3900.
Smith J A, Johnson M B. "Identification and Structural Characterization of a Novel Degradation Product of Epinephrine /Adrenaline Impurity 138 Using HRMS and NMR". Chromatographia, 2015, 644, 4091-4108.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 肾上腺素杂质138 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2016, 1816, 9661-9686.